Published in J Cereb Blood Flow Metab on June 01, 1999
Erythropoietin Effects After Traumatic Brain Injury | NCT00260052
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A (2000) 5.20
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A (2004) 3.40
Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol (2000) 2.61
Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med (2003) 2.37
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A (2003) 2.28
Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A (2002) 2.16
Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2002) 2.08
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A (2003) 1.88
The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat Protoc (2009) 1.87
Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A (2002) 1.66
Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury. J Neurosurg Pediatr (2010) 1.57
Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci (2012) 1.55
Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br J Pharmacol (2003) 1.54
Role of erythropoietin in the brain. Crit Rev Oncol Hematol (2007) 1.50
Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro (2012) 1.50
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46
A systematic review and meta-analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metab (2009) 1.45
Hypoxic preconditioning protects against ischemic brain injury. NeuroRx (2004) 1.44
Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx (2006) 1.37
Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics (2009) 1.36
Survival and proliferative roles of erythropoietin beyond the erythroid lineage. Expert Rev Mol Med (2008) 1.36
Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br J Pharmacol (2007) 1.35
Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics (2012) 1.29
Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci (2008) 1.28
Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev Neurosci (2009) 1.26
Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res (2005) 1.26
Targeting astrocytes for stroke therapy. Neurotherapeutics (2010) 1.25
Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Malar J (2008) 1.25
Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB. Curr Neurovasc Res (2006) 1.22
Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A (2002) 1.22
The receptor that tames the innate immune response. Mol Med (2012) 1.19
Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One (2009) 1.18
TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc Natl Acad Sci U S A (2008) 1.17
Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med (2009) 1.14
Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair? Front Physiol (2012) 1.12
Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling. PLoS One (2010) 1.12
Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment. J Neurochem (2009) 1.10
Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem (2009) 1.08
Science review: recombinant human erythropoietin in critical illness: a role beyond anemia? Crit Care (2004) 1.07
Unexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor function. Physiology (Bethesda) (2014) 1.07
Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev (2003) 1.06
Hypoxia inducible factor-1: its potential role in cerebral ischemia. Cell Mol Neurobiol (2012) 1.05
A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A (2005) 1.03
Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection. Exp Transl Stroke Med (2010) 1.03
The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. Eur J Clin Pharmacol (2005) 1.01
Erythropoietin regulates hypoxic ventilation in mice by interacting with brainstem and carotid bodies. J Physiol (2005) 1.00
Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons. Proc Natl Acad Sci U S A (2009) 0.99
Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke. Stroke (2013) 0.98
Involvement of erythropoietin in retinal ischemic preconditioning. Anesthesiology (2009) 0.97
A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol (2002) 0.97
Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke. Neurobiol Dis (2010) 0.97
Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling. J Neurosci (2012) 0.95
Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension. Cell Mol Neurobiol (2007) 0.95
Erythropoietin in spinal cord injury. Eur Spine J (2008) 0.95
Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis. Clin Exp Immunol (2010) 0.94
Growth factors in ischemic stroke. J Cell Mol Med (2009) 0.94
Differential effects of HIF-1 inhibition by YC-1 on the overall outcome and blood-brain barrier damage in a rat model of ischemic stroke. PLoS One (2011) 0.94
The central role of aquaporins in the pathophysiology of ischemic stroke. Front Cell Neurosci (2015) 0.93
General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain. PLoS One (2011) 0.93
Catalpol increases brain angiogenesis and up-regulates VEGF and EPO in the rat after permanent middle cerebral artery occlusion. Int J Biol Sci (2010) 0.93
Neuroplasticity and the next wave of antidepressant strategies. Front Cell Neurosci (2013) 0.92
The effects of erythropoietin dose titration during high-fat diet-induced obesity. J Biomed Biotechnol (2011) 0.92
Thrombopoietin protects the brain and improves sensorimotor functions: reduction of stroke-induced MMP-9 upregulation and blood-brain barrier injury. J Cereb Blood Flow Metab (2010) 0.92
Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. J Neuroinflammation (2013) 0.92
Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward? J Investig Med (2011) 0.92
Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke. PLoS One (2014) 0.92
Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives. Front Cell Neurosci (2013) 0.91
Safety and efficacy of erythropoietin in traumatic brain injury patients: a pilot randomized trial. Crit Care Res Pract (2010) 0.91
Erythropoietin action in stress response, tissue maintenance and metabolism. Int J Mol Sci (2014) 0.91
Effect of erythropoietin on Glasgow Coma Scale and Glasgow Outcome Sale in patient with diffuse axonal injury. J Res Med Sci (2012) 0.91
Erythropoietin: still on the neuroprotection road. Ther Adv Neurol Disord (2012) 0.90
The role of erythropoietin as an inhibitor of tissue ischemia. Int J Biol Sci (2008) 0.89
Pharmacologic preconditioning: translating the promise. Transl Stroke Res (2010) 0.89
Erythropoietin signaling: a novel regulator of white adipose tissue inflammation during diet-induced obesity. Diabetes (2014) 0.88
EPO promotes bone repair through enhanced cartilaginous callus formation and angiogenesis. PLoS One (2014) 0.88
Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia. J Bioenerg Biomembr (2009) 0.87
Developmental and pathological angiogenesis in the central nervous system. Cell Mol Life Sci (2014) 0.86
Systemic injection of recombinant human erythropoietin after focal cerebral ischemia enhances oligodendroglial and endothelial progenitor cells in rat brain. Anat Cell Biol (2010) 0.86
Bench-to-bedside review: critical illness-associated cognitive dysfunction--mechanisms, markers, and emerging therapeutics. Crit Care (2006) 0.86
Evidence of receptor-mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia. J Pharmacol Exp Ther (2010) 0.86
Erythropoietin in brain development and beyond. Anat Res Int (2012) 0.86
Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation. J Cancer Res Clin Oncol (2014) 0.86
The Janus-faced effects of hypoxia on astrocyte function. Neuroscientist (2009) 0.85
The impact of erythropoietin on short-term changes in phosphorylation of brain protein kinases in a rat model of traumatic brain injury. J Cereb Blood Flow Metab (2009) 0.85
Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. BMC Biol (2011) 0.85
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci (2015) 0.84
High dose erythropoietin increases brain tissue oxygen tension in severe vasospasm after subarachnoid hemorrhage. BMC Neurol (2012) 0.84
A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism. Genes Brain Behav (2012) 0.84
The neurobiology of erythropoietin. Cell Mol Neurobiol (2011) 0.84
Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke. Exp Neurol (2015) 0.84
The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats. Eur Spine J (2006) 0.83
Epo and other hematopoietic factors. Semin Fetal Neonatal Med (2007) 0.83
Erythropoietin reduces neuronal cell death and hyperalgesia induced by peripheral inflammatory pain in neonatal rats. Mol Pain (2011) 0.83
The neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats. Korean J Pediatr (2010) 0.82
Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis. Ther Adv Neurol Disord (2008) 0.82
Spinal vascular endothelial growth factor (VEGF) and erythropoietin (EPO) induced phrenic motor facilitation after repetitive acute intermittent hypoxia. Respir Physiol Neurobiol (2012) 0.82
Pharmacodynamic analysis of stress erythropoiesis: change in erythropoietin receptor pool size following double phlebotomies in sheep. Biopharm Drug Dispos (2011) 0.81
Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE. Eur J Nucl Med Mol Imaging (2010) 0.81
Trophic factors and stem cells for promoting recovery in stroke. J Vasc Interv Neurol (2010) 0.81
Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol (1996) 5.52
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med (2001) 5.28
Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol (2000) 2.61
Landscape connectivity influences gene flow in a roe deer population inhabiting a fragmented landscape: an individual-based approach. Mol Ecol (2004) 1.88
Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U S A (1995) 1.77
Schmallenberg virus: a seroprevalence survey in cattle and sheep, France, winter 2011-2012. Vet Rec (2013) 1.65
Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res (2002) 1.64
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
The concept of coupling blood flow to brain function: revision required? Ann Neurol (1987) 1.58
Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria. Eur Respir J (2010) 1.57
Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc Natl Acad Sci U S A (1996) 1.46
The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res (1995) 1.43
Extreme sex-biased dispersal in the communally breeding, nonmigratory Bechstein's bat (Myotis bechsteinii). Mol Ecol (2002) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia (2000) 1.41
Autism and genetics: clinical approach and association study with two markers of HRAS gene. Am J Med Genet (1995) 1.40
Plasma superoxide dismutase and glutathione peroxidase activity in sporadic amyotrophic lateral sclerosis. J Neurol Sci (1997) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J Cereb Blood Flow Metab (1988) 1.39
Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res (1976) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. J Biol Chem (1995) 1.29
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor-1 alpha. Biochem Biophys Res Commun (1996) 1.23
The extended genetic diversity of BVDV-1: typing of BVDV isolates from France. Vet Res Commun (2007) 1.21
Amine mechanisms in the cerebral circulation. Pharmacol Rev (1976) 1.21
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Cerebral circulation and norepinephrine: relevance of the blood-brain barrier. Am J Physiol (1976) 1.16
Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level. Kidney Int (1997) 1.15
Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation. Am J Hum Genet (1997) 1.15
Brain kinetics and specific binding of [11C]PK 11195 to omega 3 sites in baboons: positron emission tomography study. Eur J Pharmacol (1991) 1.15
Construction and characterization of a bovine BAC library with four genome-equivalent coverage. Genet Sel Evol (2001) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Effects of hemorrhagic hypotension on the cerebral circulation. I. Cerebral blood flow and pial arteriolar caliber. Stroke (1980) 1.13
Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic nervous system. Circ Res (1975) 1.13
Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp Neurol (2000) 1.13
Upper limit of autoregulation of cerebral blood flow in the baboon. Circ Res (1974) 1.11
A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. J Cereb Blood Flow Metab (1999) 1.11
Children of chernobyl cleanup workers do not show elevated rates of mutations in minisatellite alleles. Radiat Res (2001) 1.11
Catecholaminergic metabolism and autism. Dev Med Child Neurol (1994) 1.11
Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J Neurosci (2001) 1.10
Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J Pharmacol Exp Ther (1988) 1.10
Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J Cereb Blood Flow Metab (2000) 1.10
Expression of the gene encoding the pro-apoptotic BNIP3 protein and stimulation of hypoxia-inducible factor-1alpha (HIF-1alpha) protein following focal cerebral ischemia in rats. Neurochem Int (2006) 1.10
Angiopoietin-1-induced PI3-kinase activation prevents neuronal apoptosis. FASEB J (2003) 1.08
Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther (1988) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Rapid communication: melanocyte stimulating hormone receptor (MC1R) maps to bovine chromosome 18. J Anim Sci (1996) 1.07
Comparison of RBG-banded karyotypes of cattle, sheep, and goats. Cytogenet Cell Genet (1991) 1.06
Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death. Neuroreport (2001) 1.06
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Migraine and the blood-brain barrier. Lancet (1977) 1.04
Evaluation of the ratio of cerebral blood flow to cerebral blood volume as an index of local cerebral perfusion pressure. Brain (1998) 1.04
Effect of stimulation of the sphenopalatine ganglion on cortical blood flow in the rat. J Cereb Blood Flow Metab (1988) 1.02
Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome. Osteoporos Int (2013) 1.01
Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (1991) 1.00
Sex-biased dispersal patterns depend on the spatial scale in a social rodent. Proc Biol Sci (2009) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: a quantitative analysis of infarction volume. Stroke (1997) 0.99
Influence of endogenous norepinephrine on cerebral blood flow and metabolism. Am J Physiol (1976) 0.98
Presence of glycerol and fatty acids in the C-terminal end of a variant surface glycoprotein from Trypanosoma equiperdum. Biochem Biophys Res Commun (1983) 0.97
Effects of 5-hydroxytryptamine on pial arteriolar calibre in anaesthetized cats. J Physiol (1977) 0.97
Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat. Brain Res (1988) 0.97
Heterogeneous vasomotor responses of anatomically distinct feline cerebral arteries. Br J Pharmacol (1988) 0.97
In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke (1993) 0.96
Neuroprotection after focal cerebral ischaemia in hyperglycaemic and diabetic rats. Neurosci Lett (1995) 0.95
Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in mice. Stroke (1999) 0.94
Indoleaminergic mechanisms in brain vessels; localization, concentration, uptake and in vitro responses of 5-hydroxytryptamine. Acta Physiol Scand (1984) 0.93
Relationships between high oxygen extraction fraction in the acute stage and final infarction in reversible middle cerebral artery occlusion: an investigation in anesthetized baboons with positron emission tomography. J Cereb Blood Flow Metab (1996) 0.93
Central serotonergic nerves project to the pial vessels of the brain. Nature (1983) 0.93
New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development. J Med Chem (1998) 0.93
Hepatic metabolism of dietary alpha-linolenic acid in suckling rats, and its possible importance in polyunsaturated fatty acid uptake by the brain. Ann Nutr Metab (1986) 0.92
Calcium antagonists: effects on cerebral blood flow and blood-brain barrier permeability in the rat. Br J Pharmacol (1983) 0.92
Effect of adenosine triphosphate and some derivatives on cerebral blood flow and metabolism. J Physiol (1979) 0.92
The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: experimental and pathophysiological considerations. J Chem Neuroanat (2000) 0.91
The ischaemic penumbra. Curr Opin Neurol (2001) 0.91
Desflurane affords greater protection than halothane against focal cerebral ischaemia in the rat. Br J Anaesth (2003) 0.90
Oxygen-regulated expression of TGF-beta 3, a growth factor involved in trophoblast differentiation. Placenta (2003) 0.90
Influence of extracellular calcium and calcium antagonists on contractions induced by potassium and prostaglandin F2 alpha in isolated cerebral and mesenteric arteries of the cat. Br J Pharmacol (1983) 0.90
Evidence against cerebral vasospasm during acutely induced hypertension. Brain Res (1976) 0.89
Comparative assessment of enzyme-linked immunosorbent assay and Western blot for the diagnosis of toxocariasis in patients with skin disorders. Br J Dermatol (2009) 0.89
The quantification of brain lesions with an omega 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration. Brain Res (1990) 0.89
Matrix therapy in regenerative medicine, a new approach to chronic wound healing. J Biomed Mater Res A (2009) 0.89
Indoor fungal contamination of moisture-damaged and allergic patient housing analysed using real-time PCR. Lett Appl Microbiol (2009) 0.89
Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia. J Neurochem (1998) 0.89
Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography. J Neurosci Methods (1993) 0.88
The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive. Kidney Int (1997) 0.88
Alteration of Na,K-ATPase isoenzymes in diabetic cardiomyopathy: effect of dietary supplementation with fish oil (n-3 fatty acids) in rats. Diabetologia (1997) 0.88